WHAT IS DYSPORT®
(abobotulinumtoxinA) FOR INJECTION?
On the market for 10 years, Dysport is an FDA-approved injectable treatment for the temporary improvement of the appearance of moderate to severe frown lines (glabellar lines) between the eyebrows in adults less than 65 years of age.1 Dysport is a neuromodulator, an injection of a small amount of botulinum toxin that treats frown lines when injected into underlying muscle, causing it to relax and gradually smooth out the appearance of the frown lines between the eyebrows.2
Frown lines are not just caused by aging, but from constant repetitive movements and muscle contractions,3 which means they can develop in younger adults too. If you’re starting to notice frown lines that are bothering you, it might be time to ask your specialist about Dysport.
HOW CAN I PREPARE FOR MY TREATMENT?
More than 400,000 unique patients are treated with Dysport each year in the U.S., so know that you’re not alone in seeking treatment.4 Take the time to find a qualified specialist in your area that you feel comfortable with. It is important to see a specialist who has experience administering Dysport and knowledge of facial anatomy so you can get natural-looking results.
Don’t be afraid to ask your specialist questions! Get on the same page with your specialist about the look that you are trying to achieve—it’s important that you have the same goals in mind.
WHAT CAN I EXPECT DURING MY TREATMENT?
Dysport is a quick (10-20 minute) procedure with minimal downtime, using a relatively small needle. During treatment, you will receive an injection into each
of the five points between and over the eyebrows, two injection points above each eyebrow in the corrugator muscle and one injection point between the eyebrows
in the procerus muscle.1 Ask your specialist about any precautions you should take
after treatment. The most common side effects to be aware of after treatment are nose and throat irritation, headache, injection site pain and skin reaction, upper respiratory tract infection, eyelid swelling, sinus inflammation and nausea.1
WHAT RESULTS WILL I SEE?
In Dysport clinical studies, more than half of users saw an improvement in their frown lines in just 2-3 days.5-7*+ Don’t be afraid of a frozen look! Rather than freezing the treated area, Dysport relaxes the muscles that make you look angry or sad to provide natural-looking results.4 If you love your new look, talk to your specialist to develop a treatment schedule. As with any botulinum toxin product,
you need to wait at least three months between treatments, and results may last up to five months.4,5,z8,# Don’t be surprised if you’re still loving your look at your next
appointment — even four months after Dysport treatment, users reported looking at least four years younger than they did before their treatment.1,4,9,≡ In fact, 97 percent of users who tried Dysport reported that they would receive the treatment again.10,*,†,‡
For more information, visit www.dysportusa.com. The site offers a variety of resources including finding an experienced injector.
*A secondary endpoint based on Kaplan-Meier estimates of cumulative rate of
time to onset of response. The median time to onset of response was 3 days in GL-1
(Dysport 55/105 [52%], Placebo 3/53 [6%] and GL-2 (Dysport 36/71 [51%], Placebo
9/71 [13%]), and 2 days in GL-3 (Dysport 110/200 [55%], Placebo 4/100 [4%]).
+Users = clinical trial subjects #GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline utilizing data from two doubleblinded, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
**Subject’s satisfaction and self-perception reported 3 weeks after treatment n=531).
†Design: Multicenter, prospective, non-interventional observational study conducted in France, Germany, Spain and the United Kingdom (n=533). Subjects were eligible if the investigator had decided to prescribe Dysportaccording to the labeling. Subjects completed questionnaires at 3 weeks and 4 months after treatment.
≡Results based on subject questionnaire (FACE-Q Age Appraisal VAS), mITT
population, 1.5 mL and 2.5 mL reconstitution, N=60.2 ‡Subject’s satisfaction and self perception reported 3 weeks after treatment (n=531).
